MARK G FOLETTA Insider Trading $RGLS Regulus Therapeutics Inc.
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).
MARK G FOLETTA in Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: Director
Holdings: 81,910 shares
Current Value: $114,674
Latest Transaction: Dec 06 2017
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G FOLETTA in Regulus Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 06 2017 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Grant | A | 0.89 | 71,910 | 64,000 | 81,910 | 10 K to 81.9 K (+719.10 %) |
| Jun 02 2017 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 1.45 | 30,000 | 43,500 | 30,000 | |
| Jun 03 2016 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
| Aug 13 2015 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Buy | P | 7.64 | 10,000 | 76,405 | 10,000 | 0 to 10 K |
| Jun 26 2015 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 |
Page: 1